Maggot debridement therapy: Rescuing limbs from amputationJun 5, 2023
Maggot Debridement Therapy (MDT) has a fascinating history that dates back to the early 20th century. Here is a chronological account of its development and implementation:
In the 1920s, William Baer discovered the therapeutic effect of L. sericata larvae (maggots) in wound healing. This finding laid the foundation for further exploration and research into maggot-based treatments. During the 1940s, the advent of antibiotics and advanced surgical techniques shifted the focus away from maggot therapy. The medical community became more reliant on these new methods, leading to a decline in the use of MDT. In the 1990s, maggot therapy made a resurgence as a response to the emergence of drug-resistant bacterial strains. The effectiveness of maggots in combating such infections led to renewed interest in MDT as a viable treatment option. Mechanisms and advantages of Maggot Debridement Therapy Maggot debridement therapy employs maggots to hasten the process of debridement, which involves the removal of foreign matter and necrotic tissue from a poorly healing wound. The therapy offers several advantages, including its cost-effectiveness, time efficiency, safety, and simplicity. The mechanisms of MDT include the enzymatic liquefaction of necrotic tissue, destruction of bacteria in the alimentary tract, and the excretion and secretion of maggots that contain antibacterial and healing properties. Additionally, the high pH created by the maggots inhibits the growth of microorganisms. MDT has been found to reduce necrotic tissue, prevent and reduce infection, enhance wound healing, and provide rapid and effective results. Regulation and availability In the United States, medicinal maggots are regulated by the Food and Drug Administration (FDA) as a prescription-only, single-use medical device. In other countries, they may be regulated as drugs. Currently, at least 24 laboratories supply medical-grade maggots to therapists and patients in over 30 countries. Maggot Debridement Therapy in Malaysia In Malaysia, Maggot Debridement Therapy (MDT) was first attempted in the early 2000s. Dr Nazni Wasi Ahmad (pix), a Research Officer at the Institute for Medical Research, spearheaded the development of MDT using Lucilia Cuprina, the local species of blowfly. Malaysia became the first country in South East Asia to adopt this therapy. The successful implementation of MDT in hospitals since 2007 has treated over 6,000 patients. Process and benefits of MDT Maggot debridement therapy involves applying sterile maggots to the wound, which then feed on the necrotic tissue, promote wound healing, and stimulate the growth of new tissue. This therapy has proven effective not only for diabetic patients but also for any wounds that have sufficient oxygen supply. Patients who have undergone MDT have experienced faster healing, shorter hospital stays, and reduced occupancy of hospital beds. It is worth noting that MDT is provided in 51 hospitals across Malaysia as listed below and is a halal treatment option. Maggot Debridement Therapy, with its long history and recent resurgence, offers a unique approach to wound care. Alongside other debridement methods such as surgical, ultrasonic, hydrostatic, and autolytic debridement, MDT provides an innovative modality for the treatment of chronic wounds, particularly those caused by diabetes or diabetic conditions. Hospitals that offer MDT throughout Malaysia Kuala Lumpur 1) Kuala Lumpur Hospital 2) Ampang Hospital 3) Tanglin Health Clinic Selangor 1) Sungai Buloh Hospital 2) Kajang Hospital 3) Selayang Hospital 4) Shah Alam Hospital 5) University Malaya Medical Centre 6) 1 Malaysia Community Clinic Puchong 7) 1 Malaysia Community Clinic Seri Alam 8) Cheras Baru Health Clinic Melaka 1) Melaka Hospital 2) Military Hospital Terendak Camp 3) Jasin Health Clinic 4) Tengkera Health Clinic 5) Umbai Health Clinic Johor 1) Sultan Ismail Hospital 2) Sultanah Nora Hospital 3) Kota Tinggi Hospital 4) Mengkibol Health Clinic 5) Kluang Community Health Centre 6) Parit Jawa Health Clinic Negeri Sembilan 1) Johol Health Clinic 2) Pedas Health Clinic Kelantan 1) Hospital Raja Perempuan Zainab II 2) Tanah Merah Hospital 3) Kuala Krai Hospital 4) Tumpat Hospital 5) Universiti Sains Malaysia Hospital Terengganu 1) Sultanah Nur Zahirah Hospital 2) Hiliran Health Clinic 3) Batu Rakit Health Clinic Pahang 1) Tengku Ampuan Afzan Hospital 2) IIUM Medical Centre 3) Jerantut Hospital Kedah 1) Sultan Abdul Halim Hospital Pulau Pinang 1) Bukit Mertajam Hospital Perak 1) Seri Manjung Hospital 2) Teluk Intan Hospital 3) Slim River Hospital 4) Military Hospital Lumut 5) Bota Kiri Health Clinic 6) Kampar Health Clinic 7) Kamunting Health Clinic 8) Teluk Intan Health Clinic 9) Greentown Health Clinic Sabah 1) Queen Elizabeth II Hospital |
EXPLORE FURTHER
|
Ethnic variations in glycaemic response to simple sugars and carbohydratesImpact on blood glucose levels in Caucasians versus Asians
|
|
One in 10 prediabetic individuals progress to diabetes within a yearImpact on blood glucose levels in Caucasians versus Asians
|
|
Not so sweet: The connection between erectile health and diabetesDiabetes increases the risk of developing ED 3.5 times
|
|
Women with pre-term delivery, gestational diabetes and rheumatoid arthritis at higher risk of heart diseaseThree times at higher risk of cardiovascular deaths
|
|
Diabetes: Subtle signs you should not ignoreSubtle signs include urinating often, thirsty, urinary tract infection, weight
|
|
Diabetic retinopathy: A common cause for blindness in adultsDiabetic retinopathy is the most common eye disease
|
|
Diabetes treatments continue to evolveGlucagon-like-peptide-1 receptor agonists increases the secretion of insulin
|
|
Can diabetes be reversed?Discover the power to reverse diabetes through nutrition and lifestyle
|
